Literature DB >> 3567069

The risk of progression of lentigo maligna to lentigo maligna melanoma.

M A Weinstock, A J Sober.   

Abstract

An analysis is presented which estimates the risk of progression of lentigo maligna (LM) to lentigo maligna melanoma (LMM) in U.S. whites using three data sources: the Health and Nutrition Examination Survey I for estimation of the age-specific prevalence of LM; the Surveillance, Epidemiology, and End Results Program for estimation of the age-specific incidence of melanoma; and the data from three melanoma registries for estimation of the age-specific case fraction of LMM among all invasive melanomas. The risk varies with age and is likely to be greater than estimated here for patients who present themselves for evaluation of changes in a lesion of LM. Our analysis suggests that the risk of progression from LM to LMM is substantially lower than is commonly believed.

Entities:  

Mesh:

Year:  1987        PMID: 3567069     DOI: 10.1111/j.1365-2133.1987.tb05843.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  25 in total

Review 1.  Skin cancer - an overview for dentists.

Authors:  B J Steel
Journal:  Br Dent J       Date:  2014-05       Impact factor: 1.626

2.  Pathology of the ear.

Authors:  Ida Orengo; Kerri Robbins; Amanda Marsch
Journal:  Semin Plast Surg       Date:  2011-11       Impact factor: 2.314

3.  BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.

Authors:  Jinhyun Kim; Alexander J Lazar; Michael A Davies; Jade Homsi; Nicholas E Papadopoulos; Wen-Jen Hwu; Agop Y Bedikian; Scott E Woodman; Sapna P Patel; Patrick Hwu; Kevin B Kim
Journal:  J Cutan Pathol       Date:  2012-07-19       Impact factor: 1.587

4.  A negative skin biopsy for malignancy does not exclude the possibility of subsequent fatal disease.

Authors:  J Jacob; C A Austin; D N Slater
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

Review 5.  Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

6.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

7.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

Review 8.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

Review 9.  Skin cancer. Recognition and treatment.

Authors:  R Marks; R J Motley
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

10.  Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007.

Authors:  Sultan A Mirzoyev; Richelle M Knudson; Kurtis B Reed; Jennifer L Hou; Christine M Lohse; Marcus L Frohm; Jerry D Brewer; Clark C Otley; Randall K Roenigk
Journal:  J Am Acad Dermatol       Date:  2013-12-24       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.